Covetrus announces separation from former parent firm Henry Schein

Date: 2020-12-11   Author: Saipriya Iyer  Category: #news

Covetrus announces separation from former parent firm Henry Schein

Covetrus, the U.S-based leading firm offering animal-health technology and services, has reportedly announced that it has exited all 72 transitional services agreements with its former parent firm Henry Schein Inc. The final departure marked a pivotal milestone that will enable the firm to offer greater coordination of its business as it moves towards the next stage of its three-stage strategic plan.

Covetrus also declared an alliance within its North American commercial companies to accelerate strategic alignment between its clients and its complete scope of products as well as capabilities. The novel structure brings together the company’s North American commercial teams under combined leadership to optimize account management and aid for its customers’ businesses.

This change also unlocks new resources for the company’s global technology solution team to emphasize executing its technology roadmap including e-commerce improvements, new software, and bringing prescription management to novel geographies in 2021 and beyond. The company’s novel commercial structure also decreases duplications within the joint businesses, which hampered around 80 employees.

Ben Wolin, CEO, and President of Covetrus congratulated the team for their remarkable work in completing this separation and also thanked Henry Schein for offering constant support during the complete process. The company enters 2021 with momentum, better alignment around its customers, and emphasis on offering the substantial growth opportunities ahead, he states.

Mr. Wolin further added that this enhanced technology investment and alliance has positioned the company to win for and on behalf of its customers.

In addition, the firm has also entered into a deal to transfer its France-based distribution business, Hippocampe Caen S.A, to COVETO, effective from Dec. 31, 2020. This transfer will modestly decrease the firm’s formerly disclosed severance obligations related to its decision in Oct. 2020 to exit that business. The company continues to cater to the French market with proprietary products and practice management software.

Source credit - https://www.nasdaq.com/press-release/covetrus-completes-separation-from-former-parent-company-2020-12-09

 

 



About Author


Saipriya Iyer linkdin-boxtwitter

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

Post Recommendents

Leaded Disc MOV Market 2021-2027 Detailed Analysis and Growth Strategies, Regional and Recent Scenario Analysis

Author: Sachin Pashte

Decoding Covid-19 impact on Leaded Disc MOV market over 2021-2027, with report inclusions as growth determinants, challenges, and revenue generating prospects.

The recent study on Leaded Disc MOV market is compiled with an objective to a...


Plastic Pre-Filled Syringes Sales Market Share, Growth, Statistics, by Application, Production, Revenue & Forecast to 2027

Author: Sachin Pashte

Market Study Report adds a new research on Global Plastic Pre-Filled Syringes Sales Market for the period of 2021-2027 that shows the growth of the market is rising at a Steady CAGR to 2027.

The recent study on Plastic Pre-Filled Syringe...


Clindamycin Phosphate and Benzoyl Peroxide Sales market to showcase strong CAGR between 2027 and 2027

Author: Sachin Pashte

Primary aspects discussed in Clindamycin Phosphate and Benzoyl Peroxide Sales market research report: profit margins, pricing models, production and consumption volume, demand and supply trends, COVID-19 impact.

The recent study on Clind...